These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2890527)

  • 1. Comparison of antitumor activity of standard and investigational drugs at equivalent granulocyte-macrophage colony-forming cell inhibitory concentrations in the adhesive tumor cell culture system: an in vitro method of screening new drugs.
    Fan D; Ajani JA; Baker FL; Tomasovic B; Brock WA; Spitzer G
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1469-76. PubMed ID: 2890527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia.
    Auber ML; Horwitz LJ; Blaauw A; Khorana S; Tucker S; Woods T; Warmuth M; Dicke KA; McCredie KB; Spitzer G
    Blood; 1988 Jan; 71(1):166-72. PubMed ID: 2446678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells.
    Ajani JA; Spitzer G; Tomasovic B; Drewinko B; Hug VM; Dicke K
    Br J Cancer; 1986 Oct; 54(4):607-13. PubMed ID: 3778805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.
    Slavik M; Blanc O; Davis J
    Invest New Drugs; 1983; 1(3):225-34. PubMed ID: 6678870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions.
    Mirabelli CK; Badger AM; Sung CP; Hillegass L; Sung CM; Johnson RK; Picker D; Schwartz D; Dorman J; Martellucci S
    Anticancer Drug Des; 1989 Mar; 3(4):231-42. PubMed ID: 2930625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
    Hanauske AR; Degen D; Hilsenbeck SG; Bissery MC; Von Hoff DD
    Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity against human tumor samples of cis-diamminedichloroplatinum(II) and analogues at equivalent in vitro myelotoxic concentrations.
    Fan D; Baker FL; Khokhar AR; Ajani JA; Tomasovic B; Newman RA; Brock WA; Tueni E; Spitzer G
    Cancer Res; 1988 Jun; 48(11):3135-9. PubMed ID: 3365698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cytotoxic drugs on the development of murine granulocyte-macrophage (GM) progenitor cells.
    Cylwik B; Szmitkowski M
    Mater Med Pol; 1992; 24(4):262-5. PubMed ID: 1308058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.
    Hill BT; Whatley SA; Bellamy AS; Jenkins LY; Whelan RD
    Cancer Res; 1982 Jul; 42(7):2852-6. PubMed ID: 7200828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts.
    Newman RA; Yang J; Raymond M; Finlay V; Cabral F; Vourloumis D; Stephens LC; Troncoso P; Wu X; Logothetis CJ; Nicolaou KC; Navone NM
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):319-26. PubMed ID: 11710633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in vivo model for predicting myelotoxicity of chemotherapeutic agents using IL-3/GM-CSF transgenic humanized mice.
    Ito R; Nagai D; Igo N; Okuda Y; Sekine K; Ichimura E; Katano I; Mizushima T; Goto M; Ohnishi Y; Ito M; Okamoto K
    Toxicol Lett; 2017 Nov; 281():152-157. PubMed ID: 28947270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
    Umbach GE; Hug V; Spitzer G; Tomasovic B; Thames H; Ajani JA; Drewinko B
    J Cancer Res Clin Oncol; 1985; 109(2):130-4. PubMed ID: 3980561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro.
    Erickson-Miller CL; May RD; Tomaszewski J; Osborn B; Murphy MJ; Page JG; Parchment RE
    Cancer Chemother Pharmacol; 1997; 39(5):467-72. PubMed ID: 9054963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle status of murine megakaryocyte and granulocyte-macrophage colony-forming cells in bone marrow and spleen.
    Cen D; Levin J
    Exp Hematol; 1992 Oct; 20(9):1094-100. PubMed ID: 1468543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.
    Hill BT; Whelan RD
    Invest New Drugs; 1986; 4(4):359-65. PubMed ID: 3583643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drugs for elimination of acute lymphatic leukemia cells from autologous bone marrow.
    Blaauw A; Spitzer G; Dicke K; Drewinko B; Vellekoop L; Zander A
    Exp Hematol; 1986 Aug; 14(7):683-8. PubMed ID: 2426131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxol induces the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor in murine B-cells by stabilization of granulocyte-macrophage colony-stimulating factor nuclear RNA.
    Pluznik DH; Lee NS; Sawada T
    Cancer Res; 1994 Aug; 54(15):4150-4. PubMed ID: 7913412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: inhibition by spirogermanium hydrochloride.
    Tanowitz HB; Brennessel DJ; Baum SG; Salgo MP; Braunstein V; Wittner M
    Exp Parasitol; 1987 Aug; 64(1):57-63. PubMed ID: 3301388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.